Resources- Clinical Trial Recruitment
Dr. Auchus at the University of Michigan is recruiting for 2 phase 3 trials of atumelnant, an oral, once-daily ACTH receptor antagonist for children and adults with classic 21-hydroxylase deficiency. Adult study: Pediatric study: If you have any patients who might be interested in participating, you can message him and/or study coordinators at rauchus@med.umich.edu or CERT-coordinators@umich.edu. |